Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04134754 · ClinicalTrials.gov registry record · NA

Carbon Dioxide (CO2) Chemosensitivity and SUDEP

A NA study of Epilepsy and SUDEP, sponsored by University of Iowa.

Recruiting
Registry status
NA
Development phase
335
Enrollment target
1
Study location

NCT04134754 is a NA study of Epilepsy and SUDEP that is actively recruiting participants, run by University of Iowa. The registered enrollment target is 335 participants, below the 950-participant average among 160 other Epilepsy trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04134754, a NA study of Epilepsy and SUDEP, is actively recruiting participants, sponsored by University of Iowa.

RECRUITING
Registry status
NA
Development phase
335 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to better understand what causes Sudden Unexpected Death in Epilepsy (SUDEP). This study will enroll subjects from the University of Iowa Hospitals and Clinics (UIHC) Epilepsy Monitoring Unit (EMU) and Epilepsy Clinics. The investigators will analyze the effects of seizures on breathing, on the cardiovascular system, and on arousal. The investigators are studying these effects because some cases of SUDEP might be due, in part, to an inability to wake up or sense elevated carbon dioxide (CO2) levels when breathing is impaired. Subjects will be followed for ten years after enrollment to monitor their health.

Conditions Studied

Interventions

  • OTHER 6% Carbon dioxide/50% oxygen/balance nitrogen mixture

Study Locations (1)

Iowa

  • University of Iowa Hospitals and Clinics - Iowa City

Trial Details

FieldValue
Enrollment Target 335 participants
Start Date 2019-12-12
Est. Completion 2029-10-01
Phase NA

Sponsor

University of Iowa

228 total trials

What the Registry Record Tells You About NCT04134754

The ClinicalTrials.gov registry entry for NCT04134754 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 335 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 950-participant average among 160 other Epilepsy trials with a reported enrollment target (65% lower). The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which 6% Carbon dioxide/50% oxygen/balance nitrogen mixture is the first listed.

NCT04134754 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT04134754 about?

NCT04134754 is a clinical study titled "Carbon Dioxide (CO2) Chemosensitivity and SUDEP". The purpose of this research study is to better understand what causes Sudden Unexpected Death in Epilepsy (SUDEP). This study will enroll subjects from the University of Iowa Hospitals and Clinics (UIHC) Epilepsy Monitoring Unit (EMU) and Epilepsy Clinics. The investigators will analyze the effects...

What is the current status of trial NCT04134754?

This trial is currently recruiting. It is a NA study. The enrollment target is 335 participants. The study started on 2019-12-12. Estimated completion is 2029-10-01.

What conditions does trial NCT04134754 study?

This clinical trial studies the following conditions: Epilepsy, SUDEP.

What interventions are being tested in trial NCT04134754?

The interventions under investigation include: 6% Carbon dioxide/50% oxygen/balance nitrogen mixture (OTHER).

Who is sponsoring clinical trial NCT04134754?

This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04134754 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.